Palliare, a Galway, Ireland-based safe operating room company, closed an $8m Series A funding round.
The round was led by Seroba Life Sciences, with participation from SCM AD Ventures, Western Development Commission, and several private investors. In conjunction with the funding, Jennifer McMahon, Principal at Seroba, will join Palliare’s board.
The company intends to use the funds to support US commercial launch activities related to its EVA15 insufflator and smoke evacuation system, as well as new Research & Development activities.
Founded in 2018 as a spinout from Irish gastro-diagnostic company Crospon, which was acquired by Medtronic (NYSE:MDT) in 2017, Palliare is dedicated to advancing smoke evacuation and insufflation technologies for laparoscopic, endoluminal, endoscopic and robotic surgery.
Its first product, The EVA15 insufflator and smoke evacuation system, is designed to create a safer operating room environment and deliver insufflation and smoke evacuation performance to meet the particular demands of laparoscopic, endoluminal, endoscopic, and robotic surgical procedures.
The company, which has US headquarters in Oceanside, CA, has appointed Julie Tupen as US Vice President of Sales. She brings extensive commercial experience to the management team from having previously worked with such companies as Covidien, Invuity, and most recently Hologic.
FinSMEs
28/06/2021